| CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ... Jama 302 (4), 385-393, 2009 | 1353 | 2009 |
| Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance Y Stern, EM Arenaza‐Urquijo, D Bartrés‐Faz, S Belleville, M Cantilon, ... Alzheimer's & Dementia 16 (9), 1305-1311, 2020 | 806 | 2020 |
| CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease K Buerger, M Ewers, T Pirttilä, R Zinkowski, I Alafuzoff, SJ Teipel, ... Brain 129 (11), 3035-3041, 2006 | 723 | 2006 |
| Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review K Jekel, M Damian, C Wattmo, L Hausner, R Bullock, PJ Connelly, ... Alzheimer's research & therapy 7 (1), 1-20, 2015 | 530 | 2015 |
| Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance M Ewers, C Walsh, JQ Trojanowski, LM Shaw, RC Petersen, CR Jack Jr, ... Neurobiology of aging 33 (7), 1203-1214. e2, 2012 | 429 | 2012 |
| Implementation of subjective cognitive decline criteria in research studies JL Molinuevo, LA Rabin, R Amariglio, R Buckley, B Dubois, KA Ellis, ... Alzheimer's & Dementia 13 (3), 296-311, 2017 | 401 | 2017 |
| sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ... EMBO molecular medicine 8 (5), 466-476, 2016 | 399 | 2016 |
| Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. H Hampel, M Ewers, K Burger, P Annas, A Mortberg, A Bogstedt, L Frolich, ... Journal of Clinical Psychiatry 70 (6), 922, 2009 | 395 | 2009 |
| Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia M Ewers, RA Sperling, WE Klunk, MW Weiner, H Hampel Trends in neurosciences 34 (8), 430-442, 2011 | 380 | 2011 |
| Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease C Plant, SJ Teipel, A Oswald, C Böhm, T Meindl, J Mourao-Miranda, ... Neuroimage 50 (1), 162-174, 2010 | 371 | 2010 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 335 | 2022 |
| Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment SJ Teipel, C Born, M Ewers, ALW Bokde, MF Reiser, HJ Möller, H Hampel Neuroimage 38 (1), 13-24, 2007 | 270 | 2007 |
| Levels of β-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment Z Zhong, M Ewers, S Teipel, K Bürger, A Wallin, K Blennow, P He, ... Archives of general psychiatry 64 (6), 718-726, 2007 | 269 | 2007 |
| A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms E Baykara, B Gesierich, R Adam, AM Tuladhar, JM Biesbroek, HL Koek, ... Annals of neurology 80 (4), 581-592, 2016 | 250 | 2016 |
| Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury M Suárez-Calvet, MÁ Araque Caballero, G Kleinberger, RJ Bateman, ... Science translational medicine 8 (369), 369ra178-369ra178, 2016 | 233 | 2016 |
| Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ... Alzheimer's & Dementia 15 (2), 292-312, 2019 | 214 | 2019 |
| Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI M Ewers, K Buerger, SJ Teipel, P Scheltens, J Schröder, RP Zinkowski, ... Neurology 69 (24), 2205-2212, 2007 | 198 | 2007 |
| Age and diagnostic performance of Alzheimer disease CSF biomarkers N Mattsson, E Rosen, O Hansson, N Andreasen, L Parnetti, M Jonsson, ... Neurology 78 (7), 468-476, 2012 | 184 | 2012 |
| Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease N Franzmeier, J Neitzel, A Rubinski, R Smith, O Strandberg, ... Nature communications 11 (1), 347, 2020 | 180 | 2020 |
| Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease M Ewers, N Franzmeier, M Suárez-Calvet, E Morenas-Rodriguez, ... Science translational medicine 11 (507), eaav6221, 2019 | 165 | 2019 |
